Botulinum toxin type B: A new injectable treatment for cervical dystonia

Expert Opinion on Investigational Drugs

Volumn 10, Issue 12, 2001, Pages 2191-2199

  Brashear, A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin; Cervical dystonia; Chemodenervation; Myobloc ; NeuroBloc

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; NEUROTOXIN; PLACEBO;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM BOTULINUM; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERABILITY; DRUG USE; DYSPEPSIA; DYSPHAGIA; DYSTONIA; FEMALE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; IMMUNOGENICITY; INFECTION; INJECTION PAIN; INJECTION SITE; MOUSE; MUSCLE SPASM; NAUSEA; NECK MUSCLE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PHYSICAL DISABILITY; UNITED STATES; XEROSTOMIA;

ANIMALS; BOTULINUM TOXINS; CLINICAL TRIALS; DYSTONIA; HUMANS; NEUROTOXINS;

EID: 0035215847     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.10.12.2191     Document Type: Article

References (33)

1. Epidemiology of dystonia in Rochester, Minnesota
2. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
3. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial
4. Botulinum toxin-assisted brow lift
5. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study
6. Botulinum toxin type A as a migraine preventive treatment
7. Botulinum toxin A for axillary hyperhidrosis (excessive sweating)
8. Botulinum toxin for chronic anal fissure
9. Therapeutic uses of botulinum toxin
10. Clinical use of botulinum toxin. National Institutes of Health
11. Development of resistance to botulinum toxin type A in patients with torticollis
12. Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
13. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
14. Pharmacological and surgical options for the treatment of cervical dystonia
15. First drug for cervical dystonia
16. Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
17. Botulinum toxin type B in the treatment of cervical dystonia: A pilot study
18. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
19. The biochemistry of botulinum toxin type B
20. Botulinum toxin injections for cervical dystonia
21. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials
22. BotB (botulinum toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study)
23. Botulinum toxin type B: An open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients
24. Botulinum toxin type F for treatment of dystonia: Long-term experience
25. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
26. Botulinum toxin: Chemistry, pharmacology, toxicity and immunology
27. Response and immunoresistance to botulinum toxin injections
28. Mouse bioassay versus Western blot assay for botulinum toxin antibodies: Correlation with clinical response
29. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections
30. Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies
31. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A
32. Clinical assessments of patients with cervical dystonia